Lili Nsango
Analyst
Lear Capital Partners
Equibles does not estimate personal net worth.
About Lili Nsango
Lili Nsango is recorded as Analyst at Lear Capital Partners. Lili Nsango has spoken on 1 investor event across 1 company, most recently for Opus Genetics, Inc. on September 9, 2026. The companies whose calls Lili Nsango spoke on are classified in the Healthcare sector.
Lili Nsango on recent calls
“Maybe following up on kind of getting more or additional color on cohort two. So given that going into pivotal design, you will be excluding patient with subpovial scaring or fibrosis.”
Affiliation history
-
Lear Capital Partners
Analyst
Transcript header (unverified)
Current